Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study

Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study

Complicated infections from multidrug-resistant Gram-negative bacteria (MDR-GNB) represent a serious problem presenting many challenges. Resistance to many classes of antibiotics reduces the probability of an adequate empirical treatment, with unfavorable consequences, increasing morbidity and morta...

Full description

Bibliographic Details
Main Authors: Rosario Cultrera, Marco Libanore, Agostino Barozzi, Erica d’Anchera, Letizia Romanini, Fabio Fabbian, Francesco De Motoli, Brunella Quarta, Armando Stefanati, Niccolò Bolognesi, Giovanni Gabutti
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Antibiotics
Subjects:
carbapenem-sparing regimen
ceftazidime/avibactam
ceftolozane-tazobactam
ESBL-producing <i>Enterobacterales</i>
healthcare-associated infections
Online Access:https://www.mdpi.com/2079-6382/9/10/640

Internet

https://www.mdpi.com/2079-6382/9/10/640

Similar Items